New treatment combination shows promise for metastatic colorectal cancer patients with rare genetic mutation

An international Phase 3 clinical trial found that metastatic colorectal cancer patients with a rare genetic tumor mutation called KRAS G12C experienced superior progression-free survival rates compar

Updated on: November 07,2023 17

New treatment combination shows promise for metastatic colorectal cancer patients with rare genetic mutation

An international Phase 3 clinical trial found that metastatic colorectal cancer patients with a rare genetic tumor mutation called KRAS G12C experienced superior progression-free survival rates compar

Updated on:November 07,2023 17

New near-infrared activated photo-oxidants kill cancer cells without oxygen

A research team led by scientists from City University of Hong Kong (CityU) has achieved a significant breakthrough by inventing a new class of near-infrared-activated photo-oxidants that can effectiv

Updated on: November 12,2023 21

New near-infrared activated photo-oxidants kill cancer cells without oxygen

A research team led by scientists from City University of Hong Kong (CityU) has achieved a significant breakthrough by inventing a new class of near-infrared-activated photo-oxidants that can effectiv

Updated on:November 12,2023 21

Universal genetic testing may improve risk stratification and treatment for rare and lethal cancer

Esophageal adenocarcinoma (EAC) is a highly lethal cancer, with a five-year survival rate of less than 20 percent. Although a precursor lesion to EAC, called Barrett's esophagus (BE), is present i

Updated on: November 19,2023 18

Universal genetic testing may improve risk stratification and treatment for rare and lethal cancer

Esophageal adenocarcinoma (EAC) is a highly lethal cancer, with a five-year survival rate of less than 20 percent. Although a precursor lesion to EAC, called Barrett's esophagus (BE), is present i

Updated on:November 19,2023 18

UCLA researchers confirm mutations that predispose patients to rare kidney cancer syndrome

Researchers at the UCLA Jonsson Comprehensive Cancer Center have confirmed that a large number of genetic variants of unknown significance are in fact verified mutations that predispose patients to a

Updated on: November 19,2023 7

UCLA researchers confirm mutations that predispose patients to rare kidney cancer syndrome

Researchers at the UCLA Jonsson Comprehensive Cancer Center have confirmed that a large number of genetic variants of unknown significance are in fact verified mutations that predispose patients to a

Updated on:November 19,2023 7

Immunotherapy for Cancer: What Are My Options?

ByJennifer WelshPublished on September 06, 2023Medically reviewed byDoru Paul, MDImmunotherapy is a relatively new approach to cancer treatment. It improves the body's immu

Updated on: November 20,2023 123

Immunotherapy for Cancer: What Are My Options?

ByJennifer WelshPublished on September 06, 2023Medically reviewed byDoru Paul, MDImmunotherapy is a relatively new approach to cancer treatment. It improves the body's immu

Updated on:November 20,2023 123

How Successful Is Immunotherapy for Breast Cancer?

ByMaxine LipnerPublished on August 18, 2023Medically reviewed byDoru Paul, MDImmunotherapycan boost your body's immune response to cancer cells and hopefully kill the

Updated on: November 20,2023 231

How Successful Is Immunotherapy for Breast Cancer?

ByMaxine LipnerPublished on August 18, 2023Medically reviewed byDoru Paul, MDImmunotherapycan boost your body's immune response to cancer cells and hopefully kill the

Updated on:November 20,2023 231

Success of Rhabdomyosarcoma Treatment in Children

Including Rarer Types of RMS Disease in AdultsByJaime R. Herndon, MS, MPHPublished on July 03, 2023Medically reviewed byDoru Paul, MDRhabdomyosarcomais a kind ofsar

Updated on: November 21,2023 56

Success of Rhabdomyosarcoma Treatment in Children

Including Rarer Types of RMS Disease in AdultsByJaime R. Herndon, MS, MPHPublished on July 03, 2023Medically reviewed byDoru Paul, MDRhabdomyosarcomais a kind ofsar

Updated on:November 21,2023 56

What Is Stage 4 Cancer?

Metastatic CancerByJennifer WelshUpdated on May 03, 2023Medically reviewed byBenjamin Leach, MDStage 4 cancer is the most advanced stage, meaningcancerhas spread to

Updated on: November 21,2023 67

What Is Stage 4 Cancer?

Metastatic CancerByJennifer WelshUpdated on May 03, 2023Medically reviewed byBenjamin Leach, MDStage 4 cancer is the most advanced stage, meaningcancerhas spread to

Updated on:November 21,2023 67

Who Gets Laryngeal (Voice Box) Cancer?

Dysplasia means precancerous, which isn’t cancer yet, but it could progressByAnna GiorgiPublished on July 24, 2023Medically reviewed byBenjamin F. Asher, MDLaryngeal cancer, al

Updated on: November 21,2023 192

Who Gets Laryngeal (Voice Box) Cancer?

Dysplasia means precancerous, which isn’t cancer yet, but it could progressByAnna GiorgiPublished on July 24, 2023Medically reviewed byBenjamin F. Asher, MDLaryngeal cancer, al

Updated on:November 21,2023 192

New biomarker advances cancer treatments

Researchers have discovered ways to enhance NIR-PIT to ensure tumours are treated sufficiently and improve patient outcomes.A biomarker based on microbubbles has been used to evaluate the success of n

Updated on: November 21,2023 27

New biomarker advances cancer treatments

Researchers have discovered ways to enhance NIR-PIT to ensure tumours are treated sufficiently and improve patient outcomes.A biomarker based on microbubbles has been used to evaluate the success of n

Updated on:November 21,2023 27

Fred Hutch experts highlight research on cancer treatment advances, survivorship and precision oncology at ASCO

At the 2023 American Society for Clinical Oncology Annual Meeting—to be held June 2-6 in Chicago, Illinois—Fred Hutchinson Cancer Center experts will present research spanning survivorship, advances i

Updated on: November 21,2023 17

Fred Hutch experts highlight research on cancer treatment advances, survivorship and precision oncology at ASCO

At the 2023 American Society for Clinical Oncology Annual Meeting—to be held June 2-6 in Chicago, Illinois—Fred Hutchinson Cancer Center experts will present research spanning survivorship, advances i

Updated on:November 21,2023 17

Cancer survivor feared recurrence, but this time it was his heart

Heart attack survivor Doug Cobb. Photo: Caitriona CobbDoug Cobb popped a couple antacid pills to calm the heartburn he'd been experiencing on and off for weeks. The 60-year-old considered he might

Updated on: December 10,2023 8

Cancer survivor feared recurrence, but this time it was his heart

Heart attack survivor Doug Cobb. Photo: Caitriona CobbDoug Cobb popped a couple antacid pills to calm the heartburn he'd been experiencing on and off for weeks. The 60-year-old considered he might

Updated on:December 10,2023 8